VC Playbook: As China Looms, Sofinnova Partners Keeps The Faith In A Resilient Europe
Executive Summary
In this first installment of VC Playbook, a new series profiling venture capital groups in biopharma and medtech, In Vivo talks to Antoine Papiernik, managing partner and chair of Sofinnova Partners – Europe’s largest and oldest VC devoted to the life sciences, with €2 billion under management.